We are live on
!
Find out more
WVP
Worth Venture Partners Portfolio holdings
AUM
$31.6M
1-Year Est. Return
28.5%
This Fund
S&P 500
This Quarter
Est. Return
+6.42%
1 Year Est. Return
+28.5%
3 Year Est. Return
+102.5%
5 Year Est. Return
+128.77%
10 Year Est. Return
–
AUM
$205M
AUM Growth
+$35.6M
(+21%)
Cap. Flow
-$35.2M
Cap. Flow
% of AUM
-17.19%
Top 10 Holdings %
Top 10 Hldgs %
38.54%
Holding
227
New
51
Increased
39
Reduced
41
Closed
39
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MRNS
Marinus Pharmaceuticals, Inc
MRNS
|
+$2.06M |
| 2 |
Digital Turbine
APPS
|
+$1.87M |
| 3 |
Merck
MRK
|
+$1.39M |
| 4 |
Pfizer
PFE
|
+$1.11M |
| 5 |
Broadwind
BWEN
|
+$1.05M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DZSI
DZS Inc. Common Stock
DZSI
|
+$3.66M |
| 2 |
Aspen Aerogels
ASPN
|
+$2.95M |
| 3 |
AVEO
AVEO Pharmaceuticals, Inc.
AVEO
|
+$2.56M |
| 4 |
Evolus
EOLS
|
+$1.72M |
| 5 |
indie Semiconductor
INDI
|
+$1.37M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.52% |
| 2 | Healthcare | 17.49% |
| 3 | Financials | 5.11% |
| 4 | Real Estate | 2.52% |
| 5 | Industrials | 2.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AIOT
126
PowerFleet Inc
AIOT
$576M
| $47.8K | 0.02% |
13,932
-5,068
| -27% | -$14.2K |
|
|
CASA
127
DELISTED
Casa Systems, Inc. Common Stock
CASA
| $46.4K | 0.02% |
36,500
+5,500
| +18% | +$16.8K |
|
|
APLS
128
CALL
DELISTED
Apellis Pharmaceuticals
APLS
| $44.5K | 0.02% |
19,200
+5,800
| +43% | +$335K |
|
129
PUT
Cinemark Holdings
CNK
$4.41B
| $40.6K | 0.02% |
179,900
+10,600
| +6% | +$129K |
|
130
CALL
BridgeBio Pharma
BBIO
$16.1B
| $39.7K | 0.02% |
+25,600
| New | +$299K |
|
|
MIRO
131
DELISTED
Miromatrix Medical Inc. Common Stock
MIRO
| $36.6K | 0.02% |
+21,800
| New | +$56.7K |
|
132
MDxHealth
MDXH
$22.7M
| $33.7K | 0.02% |
+10,400
| New | +$47.5K |
|
|
AMRS
133
CALL
DELISTED
Amyris Inc.
AMRS
| $32.5K | 0.02% |
172,400
+170,718
| +10,150% | +$244K |
|
|
SVREW
134
SaverOne 2014 Ltd Warrant
SVREW
| $31K | 0.02% |
141,364
| – | – |
|
|
EMKR
135
DELISTED
Emcore Corp
EMKR
| $27.3K | 0.01% |
+2,370
| New | +$28.9K |
|
136
PUT
AstraZeneca
AZN
$241B
| $26.9K | 0.01% |
+12,800
| New | +$1.72M |
|
137
PUT
Southwest Airlines
LUV
$23.8B
| $26.1K | 0.01% |
27,300
+9,900
| +57% | +$337K |
|
138
CALL
NovoCure
NVCR
$1.89B
| $25.9K | 0.01% |
+25,600
| New | +$2.05M |
|
|
IMBI
139
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
| $20.9K | 0.01% |
41,000
-15,000
| -27% | -$10.3K |
|
|
140
CALL
AstraZeneca
AZN
$241B
| $19.9K | 0.01% |
+9,650
| New | +$1.3M |
|
141
PUT
Microchip Technology
MCHP
$43.8B
| $18.6K | 0.01% |
12,400
-3,700
| -23% | -$295K |
|
142
PUT
iShares Morningstar Value ETF
ILCV
$1.35B
| $18.2K | 0.01% |
93,100
+29,000
| +45% | +$1.87M |
|
143
PUT
Herbalife
HLF
$1.33B
| $11.1K | 0.01% |
22,200
+900
| +4% | +$15.9K |
|
144
Praxis Precision Medicines
PRAX
$8.64B
| $10.4K | 0.01% |
+854
| New | +$36K |
|
|
MDRX
145
PUT
DELISTED
Veradigm Inc. Common Stock
MDRX
| $8.78K | ﹤0.01% |
+19,500
| New | +$316K |
|
|
GES
146
PUT
DELISTED
Guess Inc
GES
| $7.05K | ﹤0.01% |
31,700
-61,200
| -66% | -$1.31M |
|
147
PUT
Arcus Biosciences
RCUS
$3.62B
| $6.35K | ﹤0.01% |
+12,700
| New | +$243K |
|
|
148
PUT
Merck
MRK
$316B
| $5.68K | ﹤0.01% |
+12,900
| New | +$1.39M |
|
149
PUT
Neurocrine Biosciences
NBIX
$16.9B
| $4.48K | ﹤0.01% |
+12,800
| New | +$1.33M |
|
|
150
PUT
Pfizer
PFE
$145B
| $2.57K | ﹤0.01% |
+25,700
| New | +$1.11M |
|
Similar funds
VL
SP
OGC
PE
RL
AIIC
LGM
SCA
Worth Venture Partners's Q1 2023 Portfolio in Review
As of Q1 2023, Worth Venture Partners held 227 positions worth $205M, up 21% from $169M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Worth Venture Partners withdrew a net $35.2M in Q1 2023, closing 39 positions and reducing 41 holdings. Its most notable exit was Aspen Aerogels, an estimated $2.95M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Worth Venture Partners opened a new position in Marinus Pharmaceuticals, Inc worth $2.27M.
- Worth Venture Partners's largest Q1 2023 buy was Marinus Pharmaceuticals, Inc: 328,735 shares worth $2.27M.
- Worth Venture Partners added most to Digital Turbine in Q1 2023, an estimated $1.87M increase.
- Worth Venture Partners's biggest Q1 2023 reduction was DZS Inc. Common Stock, cutting an estimated $3.66M.
- Worth Venture Partners fully exited Aspen Aerogels in Q1 2023, selling an estimated $2.95M.
- Worth Venture Partners's ten largest holdings make up 39% of its $205M portfolio in Q1 2023.
- Worth Venture Partners opened 51 new positions and closed 39 in Q1 2023.
- Worth Venture Partners's portfolio value rose 21% quarter-over-quarter to $205M.
Based on Worth Venture Partners's 13F filing for Q1 2023, filed 15 May 2023.